J2782 HCPCS Level II code: Injection, avacincaptad pegol, 0.1 mg
J2782 is the HCPCS code for “Injection, avacincaptad pegol, 0.1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2782Injection, avacincaptad pegol, 0.1 mg
Short description: Inj avacincaptad pegol 0.1mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J2782 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Apr 1, 2024
Where J2782 sits
- 1J codesDrugs administered other than orally
- 2Active code J2782Injection, avacincaptad pegol, 0.1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2782 mean?
J2782 is the HCPCS code for “Injection, avacincaptad pegol, 0.1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2782?
CMS lists J2782’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2782
All J codesJ2770Injection, quinupristin/dalfopristin, 500 mg (150/350)J2777Injection, faricimab-svoa, 0.1 mgJ2778Injection, ranibizumab, 0.1 mgJ2779Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mgJ2780Injection, ranitidine hydrochloride, 25 mgJ2781Injection, pegcetacoplan, intravitreal, 1 mgJ2783Injection, rasburicase, 0.5 mgJ2785Injection, regadenoson, 0.1 mgJ2786Injection, reslizumab, 1 mgJ2787Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 mlJ2788Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)J2789Riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 ml